Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPM-based tacrolimus dosing in liver and kidney transplant
NCT03527238Phase 2Completed
- Sponsor
- University of Florida
- Start
- Sep 2018
- Primary completion
- Jun 2020
- Modality
- RNA-Targeting Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of tacrolimus in liver transplantation, kidney transplantation, sponsored by University of Florida. Started Sep 2018; status: completed.
02
Drugs
tacrolimus
03
Conditions
liver transplantationkidney transplantation
Beyond the preview
Go deeper on NCT03527238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03527238.